CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,744,863 | +19.7% | 834,827 | -2.3% | 0.01% | +25.0% |
| Q2 2023 | $19,007,108 | -5.4% | 854,252 | -7.9% | 0.00% | 0.0% |
| Q1 2023 | $20,098,552 | +8.3% | 927,911 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $18,560,334 | -27.5% | 913,852 | -8.5% | 0.00% | -33.3% |
| Q3 2022 | $25,609,000 | +12.1% | 998,792 | +4.0% | 0.01% | +20.0% |
| Q2 2022 | $22,838,000 | +1.5% | 960,339 | -3.9% | 0.01% | +25.0% |
| Q1 2022 | $22,499,000 | +9.9% | 999,080 | -3.3% | 0.00% | 0.0% |
| Q4 2021 | $20,468,000 | -4.7% | 1,033,702 | -5.3% | 0.00% | 0.0% |
| Q3 2021 | $21,482,000 | -9.8% | 1,091,585 | +0.9% | 0.00% | -20.0% |
| Q2 2021 | $23,804,000 | -7.6% | 1,081,926 | -0.0% | 0.01% | 0.0% |
| Q1 2021 | $25,748,000 | -9.2% | 1,082,243 | -0.1% | 0.01% | -16.7% |
| Q4 2020 | $28,354,000 | +43.6% | 1,083,841 | -4.5% | 0.01% | +20.0% |
| Q3 2020 | $19,752,000 | +1.5% | 1,134,841 | -1.9% | 0.01% | 0.0% |
| Q2 2020 | $19,456,000 | +40.7% | 1,156,735 | -0.5% | 0.01% | 0.0% |
| Q1 2020 | $13,827,000 | -5.9% | 1,162,862 | -4.2% | 0.01% | +25.0% |
| Q4 2019 | $14,693,000 | -15.3% | 1,214,350 | -1.1% | 0.00% | -20.0% |
| Q3 2019 | $17,356,000 | +22.4% | 1,227,823 | -3.5% | 0.01% | +25.0% |
| Q2 2019 | $14,180,000 | -5.7% | 1,271,768 | -0.7% | 0.00% | 0.0% |
| Q1 2019 | $15,043,000 | -16.1% | 1,281,316 | -4.5% | 0.00% | -33.3% |
| Q4 2018 | $17,929,000 | -1.6% | 1,341,941 | +3.2% | 0.01% | +20.0% |
| Q3 2018 | $18,222,000 | -3.2% | 1,299,714 | +8.5% | 0.01% | 0.0% |
| Q2 2018 | $18,831,000 | -3.6% | 1,197,952 | +0.9% | 0.01% | 0.0% |
| Q1 2018 | $19,526,000 | -29.6% | 1,186,951 | -22.7% | 0.01% | -28.6% |
| Q4 2017 | $27,749,000 | +51.5% | 1,536,480 | +61.9% | 0.01% | +40.0% |
| Q3 2017 | $18,316,000 | +67.6% | 949,023 | +2.4% | 0.01% | +66.7% |
| Q2 2017 | $10,931,000 | +12.7% | 926,350 | +4.7% | 0.00% | 0.0% |
| Q1 2017 | $9,696,000 | +196.4% | 884,647 | +96.3% | 0.00% | +200.0% |
| Q4 2016 | $3,271,000 | +48.1% | 450,567 | +32.6% | 0.00% | 0.0% |
| Q3 2016 | $2,208,000 | +26.0% | 339,678 | +5.9% | 0.00% | 0.0% |
| Q2 2016 | $1,752,000 | +38.1% | 320,872 | +18.4% | 0.00% | – |
| Q1 2016 | $1,269,000 | -10.0% | 271,065 | -4.2% | 0.00% | – |
| Q4 2015 | $1,410,000 | +38.8% | 283,069 | +4.7% | 0.00% | – |
| Q3 2015 | $1,016,000 | -48.0% | 270,405 | -16.8% | 0.00% | -100.0% |
| Q2 2015 | $1,953,000 | +40.7% | 324,969 | +31.1% | 0.00% | – |
| Q1 2015 | $1,388,000 | +78.2% | 247,970 | -4.5% | 0.00% | – |
| Q4 2014 | $779,000 | +5.1% | 259,790 | -6.1% | 0.00% | – |
| Q3 2014 | $741,000 | -52.3% | 276,682 | -50.1% | 0.00% | – |
| Q2 2014 | $1,552,000 | +41.9% | 554,926 | +121.2% | 0.00% | – |
| Q1 2014 | $1,094,000 | +42.1% | 250,847 | +4.6% | 0.00% | – |
| Q4 2013 | $770,000 | +4.9% | 239,751 | -48.1% | 0.00% | – |
| Q3 2013 | $734,000 | +84.4% | 462,136 | +100.7% | 0.00% | – |
| Q2 2013 | $398,000 | – | 230,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |